Muhammad Agus Mikrajab
Pusat Humaniora, Kebijakan Kesehatan dan Pemberdayaan Masyarakat Badan Litbang Kesehatan KemenKes RI

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

Associated Factors in Willingness to Shift Tobacco Expenditure Into National Health Insurance Premium Among Subsidized Members Wahidin, Mugi; Mikrajab, Muhammad Agus; Agustiya, Rozana Ika; Azteria, Veza
Kesmas Vol. 20, No. 5
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

In Indonesia, subsidized members are the largest group in the National Health Insurance program. Hence, it is essential to understand their ability to pay (ATP) based on tobacco expenditure. This study aimed to determine the ATP of subsidized members based on tobacco expenditure and factors associated with their willingness to pay (WTP). This cross-sectional study used secondary data from the National Institute of Health Research and Development. The population included all subsidized members; 19,918 were sampled for ATP, and 14,560 were WTP. The independent t-test, ANOVA, and logistic regression were performed. Results showed that ATP from tobacco expenditure ranged from USD 4 to 4.8, higher than the minimum monthly payment, and WTP ranged from USD 0.1 to 1.2. About 73.6% of respondents preferred to pay less than USD 0.3 as an additional payment, while 3.5% were willing to pay more than USD 1. The ATP was higher than the monthly payment and WTP, but only a few were willing to be non-subsidized members. Factors associated with WTP were sex, age, education level, family member, occupation, expenditure, and history of health facility utilization, implying the subsidized members should be reviewed, especially among smokers.
Economic Loss of Leptospirosis: Is It Still Appropriate to be Tropical Neglected Zoonosis Disease? Nugraheni, Wahyu Pudji; Lestyoningrum, Sinta Dewi; Ristiyanto, Ristiyanto; Putro, Wahyu Gito; Pawitaningtyas, Indah; Nuraini, Syarifah; Putri, Linta Meyla; Faisal, Debri Rizki; Noveyani, Adhista Eka; Mikrajab, Muhammad Agus
Kesmas Vol. 19, No. 5
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Leptospirosis is a tropical endemic disease that can reduce the productivity of sufferers. However, research on economic and productivity losses due to leptospirosis is rare. This study aimed to determine economic and productivity losses due to leptospirosis in the Banyumas District, Indonesia, as an endemic area. This study used a cross-sectional design and quantitative methods conducted in October 2022. Secondary data of medical records and billing information from 73 inpatients receiving treatment at a Public Hospital in the Banyumas District from February 2021 to September 2022 obtained from the hospital’s archives were used. This study examined the actual costs (direct and indirect costs) of treatment, average length of stay, and patient characteristics. Statistical tools were carried out to check the results. The results showed that over half of leptospirosis patients used insurance with an economic loss of USD 289.64 and a productivity loss value of USD 388,499. Patients infected with leptospirosis vary in age. Leptospirosis results in loss of patient productivity during treatment. Increasing prevention and control to prevent deaths and economic burdens on society and local governments is proposed to local governments.
THE COST OF TREATMENT FOR PEDIATRIC TUBERCULOSIS PATIENTS: A CROSS-SECTIONAL STUDY Lestyoningrum, Sinta Dewi; Noveyani, Adistha Eka; Putro, Wahyu Gito; Faisal, Debri Riski; Purwatiningsih, Yuni; Mikrajab, Muhammad Agus; Nugraheni, Wahyu Pudji
Indonesian Journal of Health Administration (Jurnal Administrasi Kesehatan Indonesia) Vol. 13 No. 2 (2025): Article in Press
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Tuberculosis (TB) is a leading global communicable disease. Pediatric tuberculosis, in particular, is prevalent among the population aged 0-14 years and necessitates a treatment duration of at least six months. Aims: This study aims to assess the total treatment cost of pediatric tuberculosis patients and determine the factors associated with the total cost. Methods: A cross-sectional design was employed to collect the retrospective data at a public hospital and PHC in the province-level Special Region of Yogyakarta, Indonesia. Treatment costs are categorized into the following: laboratory costs, professional costs, drug costs, medical and non-medical support costs, and miscellaneous costs. The collected data underwent both descriptive and statistical analysis using regression methods, namely logistic and probit regressions. Results: The analysis revealed that most patients were between 0 and 2 years old and most of them are school-age, with an average treatment cost of USD 62.80 per patient. The study identified laboratory costs (RR 0.198; 95% CI 0.083-0.314), professional costs (RR 9.402; 95% CI 4.108-14.698), drug costs (RR 5.269; 95% CI 2.326-8.212), and medical support costs (RR 0.223;95% CI 0.064-0.382) as the primary contributors to the total cost. Conclusion: The point of this study is that effective treatment is possible with proper financial support. To achieve a successful outcome in treating pediatric tuberculosis, it is imperative to establish an advocacy and collaboration effort to enhance the primary health services. This cooperative effort should prioritize convenient access to treatment and enhancing active case finding. Keywords: cost of illness, cost of treatment, pediatric tuberculosis